Renovo News
-
17th November 2009Dr Sharon O'Kane Wins Award...read more
-
17th November 2009Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing, will announce its preliminary results for the year ended 30 September 2009 at 7.00am on Tuesday 15 December 2009. ...read more
-
3rd November 2009RENOVO GROUP PLC(“Renovo” or “the Company”)ADAPREV™ TRIAL COMMENCES: FIRST PATIENT TREATED ...read more
-
17th September 2009Renovo Group plc will host a conference call for analysts and investors to discuss this announcement at 9.00am (BST) today. The call can be accessed with the dial-in number +44 (0)20 7138 0819 in the UK, using the confirmation code 1495235. A replay of the conference call will be available for one month using the replay number +44 (0)20 7111 1244 in the UK and the replay code 1495235#....read more
-
15th August 2009Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring, today announces that Dr....read more
-
9th June 2009Renovo Group plc will host a conference call for analysts and investors to discuss this announcement at 09:30 (BST) today. The dial-in details are: participant number: +44 (0)20 8609 1435, pa...read more
-
6th April 2009STATEMENT REGARDING POSSIBLE OFFER FOR RENOVO ...read more